Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies
Mark Pegram, MD & Joyce O’Shaughnessy, MD
Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC
Luis E. Raez, MD, FACP
Endocrine Therapy for Early -and Late- Stages Breast Cancer: Therapeutic Updates
Joyce O’Shaughnessy, MD
Management of Patients After CAR-T Therapy: Adverse Reactions and Follow Up
Brigett Brandjes, PA-C, MMSc
